Medical Health & Life Science Research News

New report shares details about the novel therapies for amyotrophic lateral sclerosis treatment drive amyotrophic lateral sclerosis pipeline growth

New report shares details about the novel therapies for amyotrophic lateral sclerosis treatment drive amyotrophic lateral sclerosis pipeline growth

Amyotrophic lateral sclerosis currently exhibits a pipeline with 72 drug candidates by P&S Market Research.

- Advertisement -
- Market Research Pro -

The study analysed that the Amyotrophic lateral sclerosis pipeline comprises of 72 drug candidates in different stages of development.

Amyotrophic lateral sclerosis is a disease that causes progression in neurodegeneration in brain and spinal cord. In Amyotrophic lateral sclerosis, the muscle does not get adequate nourishment due to which it becomes atrophic.

The disease occurs in the lateral region, an area in which spinal cord reflexes are found majorly.

- Advertisement -
- Market Research Pro -
Therefore, the degeneration leads to hardening and scarring of muscles in that region.

The progressive degeneration of neurons from brain to the spinal cord and spinal cord to the whole body can ultimately lead to their death. Amyotrophic lateral sclerosis is classified into two types, namely, sporadic and familial.

Approximately 90% to 95% of the patients suffering from the disease in the U.S. are experience the sporadic.

Browse Report Description at: https://www.psmarketresearch.com/market-analysis/amyotrophic-lateral-sclerosis-pipeline-analysis

According to the route of administration analysis, most of the drug candidates are being developed to be administered by oral route.

The research also found that various companies have collaborated for the development of amyotrophic lateral sclerosis pipeline. In March 2013, Dainippon Sumitomo Pharma Co., Ltd.

signed a research, development and commercial licensing agreement with Edison Pharmaceuticals, Inc. for EPI-743 and EPI-589 in Japan.

Explore Report at: www.psmarketresearch.com/market-an…is/report-sample

Some of the key players developing drugs for Amyotrophic lateral sclerosis include FlexPharma, Inc., Orion Corporation, Genervon Biopharmaceuticals, LLC, and others.

News From

P&S Market ResearchP&S Market Research
Category: Market Research Publishers and RetailersCompany profile: PS Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries. With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our pub ...